Use of peptidic compounds for the prophylaxis and treatment of chronic headache

Details for Australian Patent Application No. 2005232395 (hide)

Owner Schwarz Pharma AG

Inventors Scheller, Dieter; Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2005232395

PCT Pub. Number WO2005/099740

Priority 60/562,681 16.04.04 US

Filing date 15 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 9 September 2010

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/099740 Priority application(s): WO2005/099740

9 September 2010 Application Accepted

  Published as AU-B-2005232395

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232396-Vaccination against malignant melanoma using BCG and/or vaccinia

2005232392-Method and compositions for reducing oxidative stress in an animal